Compare TIGO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIGO | DVA |
|---|---|---|
| Founded | 1990 | 1994 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Misc Health and Biotechnology Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 14.9B |
| IPO Year | 1997 | 2003 |
| Metric | TIGO | DVA |
|---|---|---|
| Price | $92.67 | $228.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $68.30 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 1.3M | 638.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.87 |
| Revenue | N/A | ★ $13,643,069,000.00 |
| Revenue This Year | $41.91 | $3.85 |
| Revenue Next Year | $4.06 | $3.07 |
| P/E Ratio | ★ $10.21 | $81.42 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $39.01 | $101.00 |
| 52 Week High | $100.75 | $247.49 |
| Indicator | TIGO | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 50.25 |
| Support Level | $91.51 | $230.00 |
| Resistance Level | $94.73 | $239.64 |
| Average True Range (ATR) | 3.05 | 5.83 |
| MACD | -0.68 | -1.64 |
| Stochastic Oscillator | 29.54 | 13.60 |
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia, Nicaragua, Panama, El Salvador, Guatemala, Paraguay, Colombia, Ecuador, Uruguay, and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 145 million people, serving nearly 60 million customers. Its fixed-line networks reach 22 million homes, serving about 5.6 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm also formed a joint venture to acquire Telefónica's operations in Chile.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.